MUC16 and pancreatic intraductal papillary-mucinous neoplasm: To the best of our knowledge, this is the first article to propose optimum cut-off values for CA19-9, CA125 and CEA to predict invasive pancreatic IPMNs and to evaluate different combinations of these biomarkers.